We performed serial measurements of sFlt-1 and PlGF serum levels in 11 patients with suspected preeclampsia who received daily weight adjusted low molecular weight heparin (LMWH) for DVT-prophylaxis to investigate the influence of heparin administration on the diagnostic assays of sFlt-1 and PlGF. The gene discussed is PGF; the disease is preeclampsia.